APA (7th ed.) Citation

Dijkstra, S., Govers, T. M., Hendriks, R. J., Schalken, J. A., Van Criekinge, W., Van Neste, L., . . . Oort, I. M. (2017). Cost-effectiveness of a new urinary biomarker-based risk score compared to standard of care in prostate cancer diagnostics - a decision analytical model. BJU International, 120(5), 659. https://doi.org/10.1111/bju.13861

Chicago Style (17th ed.) Citation

Dijkstra, Siebren, Tim M. Govers, Rianne J. Hendriks, Jack A. Schalken, Wim Van Criekinge, Leander Van Neste, Janneke P.C Grutters, John P. Michiel Sedelaar, and Inge M. Oort. "Cost-effectiveness of a New Urinary Biomarker-based Risk Score Compared to Standard of Care in Prostate Cancer Diagnostics - a Decision Analytical Model." BJU International 120, no. 5 (2017): 659. https://doi.org/10.1111/bju.13861.

MLA (9th ed.) Citation

Dijkstra, Siebren, et al. "Cost-effectiveness of a New Urinary Biomarker-based Risk Score Compared to Standard of Care in Prostate Cancer Diagnostics - a Decision Analytical Model." BJU International, vol. 120, no. 5, 2017, p. 659, https://doi.org/10.1111/bju.13861.